“If what [Republicans] describe as socialism is the best path to achieve the end of the HIV epidemic, then we ourselves cannot dismiss the Sanders campaign with the same zeal,” activist Brian Gaither writes.
All over the U.S., people taking PrEP are being urged to go with Descovy instead of Truvada. Our HIV prevention expert answers the question: Is it worthwhile to make the switch?
Ready, Set, PrEP expands access to pre-exposure prophylaxis meds, but it doesn't cover other costs.
Given similar efficacy and the renal and bone benefits, TAF/FTC should be favored over TDF/FTC. But as David Wohl, M.D., explains, the reality isn't so simple.
"Let these names burn in your heart to fuel your desire to live."
As Gilead pressures health care providers to switch to the newer drug, here's some information to make sure you can make the best decision for your health.
While many celebrated the FDA approval of Descovy for PrEP earlier this month, advocates wonder whether it will make biomedical HIV prevention more or less accessible to those most in need.
Brand Name: Descovy Other Name(s): FTC/TAF, emtricitabine/tenofovir AF, emtricitabine/tenofovir alafenamide fumarate Drug Class: Combination Drugs